Inventor
Babu J. Mavunkel
Inventor
Sunnyvale, CA, US
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds41%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes16%
C07KPeptides11%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
7,488,744'Indole-type derivatives as inhibitors of p38 kinase'20097,304,048'Indole-type derivatives as inhibitors of p38 kinase'20077,238,712'Indole-type derivatives as inhibitors of p38 kinase'20077,220,763'Indole-type derivatives as inhibitors of p38 kinase'20077,214,679'Piperidine/piperazine-type inhibitors of p38 kinase'20077,189,739'Compounds and methods to treat cardiac failure and other disorders'20077,189,726'Benzofuran derivatives as inhibitors of p38-α kinase'20076,867,209'Indole-type derivatives as inhibitors of p38 kinase'20056,864,260'Indole-type derivatives as inhibitors of p38 kinase'20056,696,443'Piperidine/piperazine-type inhibitors of p38 kinase'20046,589,954'Compounds and methods to treat cardiac failure and other disorders'20036,541,477'Inhibitors of p38-a kinase'20036,448,257'Compounds and methods to treat cardiac failure and other disorders'20026,410,540'Inhibitors of p38-kinase'20026,340,685'Compounds and methods to treat cardiac failure and other disorders'20026,130,235'Compounds and methods to treat cardiac failure and other disorders'20005,817,756'Pseudo- and non-peptide bradykinin receptor antagonists'19985,686,565'Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins'19975,610,142'Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids'19975,552,383'Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins'19965,521,158'Pseudopeptide bradykinin receptor antagonists'19965,204,352'Compounds exhibiting anti-parasitic activity and a method for their use'19934,889,860'Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists'19894,760,069'Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists'1988Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1988–1989Patents assigned to NOVA PHARM CORP (2)· patent assignee history
1988–1997Based in Baltimore, MD, US· patent location history
1993Patents assigned to US ARMY (1)· patent assignee history
1996Patents assigned to SCIOS NOVA INC (2)· patent assignee history
1997–2009Patents assigned to SCIOS INC (19)· patent assignee history
1997Based in Timonium, MD, US· patent location history
1998–2009Based in Sunnyvale, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SCIOS INC | 19 | 1997–2009 |
| NOVA PHARM CORP | 2 | 1988–1989 |
| SCIOS NOVA INC | 2 | 1996 |
| US ARMY | 1 | 1993 |
Locations
| Location | Patents | Span |
|---|---|---|
| Sunnyvale, California, US | 17 | 1998–2009 |
| Baltimore, Maryland, US | 6 | 1988–1997 |
| Timonium, Maryland, US | 1 | 1997 |